<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteWomen&#8217;s Health &#8211; Wyss Institute</title>
		<link>https://wyss.stage.a17.io</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Thu, 30 Jul 2026 21:38:59 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.stage.a17.io/application-area/womens-health/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.9.6</generator>

		<!-- Start loop -->
		
			<item>
				<title>Gozde Basara on Engineering Safer Solutions for Cancer Survivors</title>
				<link>https://wyss.stage.a17.io/news/humans-of-the-wyss-gozde-basara-on-engineering-safer-solutions-for-cancer-survivors/</link>
        <pubDate>Wed, 20 Nov 2024 16:22:50 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
		<category><![CDATA[Women's Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41500</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Gozde Basara has never shied away from learning something new. From starting a Ph.D. in 3D Bioprinting as a mechanical engineer with no advanced knowledge of biology to taking on new artistic&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/humans-of-the-wyss-gozde-basara-on-engineering-safer-solutions-for-cancer-survivors/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/humans-of-the-wyss-gozde-basara-on-engineering-safer-solutions-for-cancer-survivors/</link>
          <title>Gozde Basara, Biofabrication Engineer. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/11/18153347/HoW-Gozde-Basara-04067.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=792acff42c7946fa6349136d642d74d5"/></url>
				</image>
        			</item>

		
			<item>
				<title>Wyss Institute’s iNodes team receives ARPA-H Sprint for Women’s Health award to advance the first implantable immune organs to treat ovarian cancer</title>
				<link>https://wyss.stage.a17.io/news/inodes-receives-arpa-h-award/</link>
        <pubDate>Tue, 12 Nov 2024 14:58:41 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Awards]]></category>
		<category><![CDATA[Community]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Women's Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41442</guid>
                            <description>iNodes is a new treatment paradigm in personalized immunotherapy with the potential to prolong the lives of many patients with advanced ovarian cancer </description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Ovarian cancer is more deadly than any other type of female reproductive organ cancer. It is estimated that in 2024, in the U.S. alone, more than 12,000 women will die from the disease because available therapies are not effective. To help overcome this striking deficit in women&rsquo;s health, ARPA&#x2d;H has selected a team at the Wyss Institute at Harvard University as&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/inodes-receives-arpa-h-award/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/inodes-receives-arpa-h-award/</link>
          <title>Gigija Goyal, Senior Scientist II. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2022/02/03113258/WoW-Girija-Goyal-Neutral-2081.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=503aad01b8edf087abbae2069ea5b85b"/></url>
				</image>
        			</item>

		
			<item>
				<title>The Wyss makes up for lost time with health innovation for women</title>
				<link>https://wyss.stage.a17.io/news/the-wyss-makes-up-for-lost-time-with-health-innovation-for-women/</link>
        <pubDate>Wed, 30 Oct 2024 12:55:28 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Community]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=41304</guid>
                            <description>How women’s health advocacy, data-driven technology innovation, cross-sector collaboration, and investment converge at the Wyss to help close the gender gap in healthcare </description>
                                        <content:encoded><![CDATA[<p>By Mariel Schoen For decades, the disparities between men&rsquo;s and women&rsquo;s health have been both obvious and overlooked. While it&rsquo;s widely understood that women and men are biologically distinct, the implications of these differences have often been ignored in medical research and innovation. At the heart of this issue is a troubling reality: many drugs on the market today were tested solely on&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/the-wyss-makes-up-for-lost-time-with-health-innovation-for-women/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/the-wyss-makes-up-for-lost-time-with-health-innovation-for-women/</link>
          <title>Wyss Director of Technology Translation & Chief Operating Officer Angelika Fretzen leads a panel discussion about what it will take to invent the future for women’s health, and illustrates how the Wyss is poised to lead this charge. Credit: Wyss Institute at Harvard University </title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/10/28124820/20240925-Wyss-Womens-Health-Symposium-DSC02439.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=76fdbe0b22e026cb10f624f3f7256ea8"/></url>
				</image>
        			</item>

		
			<item>
				<title>Progress, Potential, and Possibilities with Luba Perry, Ph.D. &#8211; Bioengineered Breast Reconstruction And Augmentation</title>
				<link>https://wyss.stage.a17.io/media-post/progress-potential-and-possibilities-with-luba-perry-ph-d-bioengineered-breast-reconstruction-and-augmentation/</link>
        <pubDate>Tue, 08 Oct 2024 14:24:03 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[3D Bioprinting]]></category>
		<category><![CDATA[Organ Engineering]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=41160</guid>
                                                <content:encoded><![CDATA[<p>Each episode of this podcast includes a discussion with fascinating people designing a better tomorrow. Luba Perry, Ph.D. is Co&#x2d;Founder and CEO of ReConstruct Bio, an innovative venture emerging from Harvard&rsquo;s Wyss Institute, aimed at redefining the fields of medical reconstruction and aesthetics with an initial application of their groundbreaking technology on breast reconstruction and&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/progress-potential-and-possibilities-with-luba-perry-ph-d-bioengineered-breast-reconstruction-and-augmentation/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/progress-potential-and-possibilities-with-luba-perry-ph-d-bioengineered-breast-reconstruction-and-augmentation/</link>
          <title>Luba Perry, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2021/06/21103731/HoW-Luba-Perry-0740.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=df27314b47a1b42b2a4d8ab4b0e8cd37"/></url>
				</image>
        			</item>

		
			<item>
				<title>Justin Scott on Engineering Proteins for Real-World Impact</title>
				<link>https://wyss.stage.a17.io/news/justin-scott-on-engineering-proteins-for-real-world-impact/</link>
        <pubDate>Wed, 26 Jun 2024 15:05:06 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
		<category><![CDATA[Protein Engineering]]></category>
		<category><![CDATA[Women's Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40307</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Years ago, Justin Scott was working in finance when a conversation with a friend who cared deeply about their science&#x2d;related job prompted him to make a change. Chasing that same job&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/justin-scott-on-engineering-proteins-for-real-world-impact/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/justin-scott-on-engineering-proteins-for-real-world-impact/</link>
          <title>Justin Scott, Scientist I. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/06/26110347/HoW-Justin-Scott-00632.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c502c3ee1f93bff7f6a959414ada24d9"/></url>
				</image>
        			</item>

		
			<item>
				<title>Human cervix modeled in microfluidic organ chip fills key women&#8217;s health gap</title>
				<link>https://wyss.stage.a17.io/news/human-cervix-modeled-in-microfluidic-organ-chip-fills-key-womens-health-gap/</link>
        <pubDate>Fri, 31 May 2024 14:55:29 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=40143</guid>
                            <description>Engineered cervix with in vivo-like mucus production, hormone sensitivity, and associated microbiome creates novel testbed for bacterial vaginosis therapeutics and other treatments</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Bacterial Vaginosis (BV) has been identified as one of the many unmet needs in women&rsquo;s health and affects more than 25% of reproductive&#x2d;aged women. It is caused by pathogenic bacteria that push the healthy microbiomes in the female vagina and cervix &ndash; the small gatekeeper canal that connects the uteruns and vagina &ndash; into a state of imbalance known as dysbiosis.</p>
<p><a href="https://wyss.stage.a17.io/news/human-cervix-modeled-in-microfluidic-organ-chip-fills-key-womens-health-gap/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/human-cervix-modeled-in-microfluidic-organ-chip-fills-key-womens-health-gap/</link>
          <title>Wyss researchers have developed a human Cervix-on-a-Chip that models the complex cervix tissue in vitro, and overcomes major limitations of existing animal and <em>in vitro</em> models to enable the study of bacterial vaginosis and development of drugs. Credit: Shutterstock</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/05/30093346/shutterstock_2079694981.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=dfc20f21950dd60f95918a0dfeac8694"/></url>
				</image>
        			</item>

		
			<item>
				<title>Mice Don’t Menstruate: Reimagining Women’s Health Using Organ Chips with Dr. Donald Ingber</title>
				<link>https://wyss.stage.a17.io/media-post/mice-dont-menstruate-reimagining-womens-health-using-organ-chips-with-dr-donald-ingber/</link>
        <pubDate>Wed, 08 May 2024 13:05:03 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Women's Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=39932</guid>
                                                <content:encoded><![CDATA[<p>In this episode, host Sharon Kedar, Co&#x2d;Founder of Northpond Ventures, is joined by Dr. Donald Ingber, Founding Director at Wyss Institute for Biologically Inspired Engineering at Harvard University. Dr. Ingber&rsquo;s commitment to following his passion has led him to countless medical and technological breakthroughs, including Organ Chip technology. These incredible chips recreate the structure and&#8230;</p>
<p><a href="https://wyss.stage.a17.io/media-post/mice-dont-menstruate-reimagining-womens-health-using-organ-chips-with-dr-donald-ingber/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/mice-dont-menstruate-reimagining-womens-health-using-organ-chips-with-dr-donald-ingber/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/05/08090409/1715026067303-e1715173469848.jpeg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=d52dca7281703715b1892f95db80187a"/></url>
				</image>
        			</item>

		
			<item>
				<title>ReConstruct: Vascularized tissue for breast reconstruction and augmentation</title>
				<link>https://wyss.stage.a17.io/technology/reconstruct/</link>
        <pubDate>Wed, 01 May 2024 10:23:28 +0000</pubDate>
        <dc:creator><![CDATA[Seth Kroll]]></dc:creator>
        		<category><![CDATA[3D printing]]></category>
		<category><![CDATA[Biological Materials]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Boston University]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Implants]]></category>
		<category><![CDATA[Organ Engineering]]></category>
		<category><![CDATA[Plastic Surgery]]></category>
		<category><![CDATA[Reconstructive surgery]]></category>
		<category><![CDATA[Vasculature]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=37539</guid>
                                                <content:encoded><![CDATA[<p>Breast cancer, the most common cancer worldwide, affects nearly 15% of all women. Most of these women undergo some kind of mastectomy to treat their cancer, and 40% choose to have breast reconstruction surgery. However, all currently available reconstruction options come with significant health risks. Artificial implants, whether filled with silicone or saline, require frequent safety monitor and&#8230;</p>
<p><a href="https://wyss.stage.a17.io/technology/reconstruct/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/technology/reconstruct/</link>
          <title></title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/05/18145033/ReConstruct-Team-Photos_Candid-04099-final.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=fdcd0d0996009d4d1bd04c723cce22b8"/></url>
				</image>
        			</item>

		
			<item>
				<title>Atlantic Health Research Spotlight: Female-Reproductive-Tract Organ Chips for Women’s Health and Fertility Studies</title>
				<link>https://wyss.stage.a17.io/media-post/atlantic-health-research-spotlight-female-reproductive-tract-organ-chips-for-womens-health-and-fertility-studies/</link>
        <pubDate>Thu, 11 Apr 2024 19:34:29 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Reproductive Health]]></category>
		<category><![CDATA[Women's Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=39675</guid>
                                                <content:encoded><![CDATA[<p>Innovation has disrupted care as we know it. Challenges with access, complex diseases, and care delivery persist, but so do areas of opportunity for emerging tech and discoveries. The Atlantic explored gene editing, artificial intelligence, climate change, weight&#x2d;loss and diabetes treatments, and more at their annual Health Summit. Wyss researchers Aakanksha Gulati, Ph.D., and Ola Gutzeit, Ph.D.</p>
<p><a href="https://wyss.stage.a17.io/media-post/atlantic-health-research-spotlight-female-reproductive-tract-organ-chips-for-womens-health-and-fertility-studies/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/media-post/atlantic-health-research-spotlight-female-reproductive-tract-organ-chips-for-womens-health-and-fertility-studies/</link>
          <title>Mark Wilson Photography</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/04/11153252/MWI-380.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=6484c73ed1b180d894e52fdc49544285"/></url>
				</image>
        			</item>

		
			<item>
				<title>Ola Gutzeit on Improving Fertility</title>
				<link>https://wyss.stage.a17.io/news/humans-of-the-wyss-ola-gutzeit-on-improving-fertility/</link>
        <pubDate>Tue, 26 Mar 2024 13:54:21 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
		<category><![CDATA[Reproductive Health]]></category>
		<category><![CDATA[Women's Health]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=39331</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. As a reproductive health specialist in the clinical setting, Ola Gutzeit discovered a lack of effective methods for enhancing fertility care. Driven by a constant desire to seek innovative&#8230;</p>
<p><a href="https://wyss.stage.a17.io/news/humans-of-the-wyss-ola-gutzeit-on-improving-fertility/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.stage.a17.io/news/humans-of-the-wyss-ola-gutzeit-on-improving-fertility/</link>
          <title>Ola Gutzeit, Research Fellowship in Reproductive Health. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-stage.imgix.net/app/uploads/2024/03/19091236/HoW-Ola-Gutzeit-05176.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=9229f8db16184e888c7062a532e36ebb"/></url>
				</image>
        			</item>

			</channel>
</rss>
